Autopsy report · NCT02142569
Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood
Cause of deathSlow enrollment
“We were unable to procure the supplement for this study.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2, Phase 3
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University, hospital or other
- Conditions
- Cholesterol Lowering
- Interventions
- Sugar Pill; Chinese Red Yeast Rice (CRYR); CRYR + TRF; Tocotrienol-enriched Fraction of Palm Oil (TRF)
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography
“Funding for the study could not be obtained.” - Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
“FDA request as study could not serve as the confirmatory trial.” - A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
“One of the drugs for the study is not commercially available.” - Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment
“The study did not receive funding.” - Early-feasibility Study to Evaluate Usability and Safety of the Watch-Transcutaneous Electrical Acustimulation (TEA) Device
“The study was not funded.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.